182 related articles for article (PubMed ID: 36633827)
1. ULBP2 is a biomarker related to prognosis and immunity in colon cancer.
Yang X; Su X; Wang Z; Yu Y; Wu Z; Zhang D
Mol Cell Biochem; 2023 Oct; 478(10):2207-2219. PubMed ID: 36633827
[TBL] [Abstract][Full Text] [Related]
2. NOX4 has the potential to be a biomarker associated with colon cancer ferroptosis and immune infiltration based on bioinformatics analysis.
Yang X; Yu Y; Wang Z; Wu P; Su X; Wu Z; Gan J; Zhang D
Front Oncol; 2022; 12():968043. PubMed ID: 36249057
[TBL] [Abstract][Full Text] [Related]
3. Investigation and verification of the clinical significance and perspective of natural killer group 2 member D ligands in colon adenocarcinoma.
Ruan GT; Wang S; Zhu LC; Liao XW; Wang XK; Liao C; Yan L; Xie HL; Gong YZ; Gan JL; Gao F
Aging (Albany NY); 2021 Apr; 13(9):12565-12586. PubMed ID: 33909599
[TBL] [Abstract][Full Text] [Related]
4. CD72, a new immune checkpoint molecule, is a novel prognostic biomarker for kidney renal clear cell carcinoma.
Tian L; Wang Y; Zhang Z; Feng X; Xiao F; Zong M
Eur J Med Res; 2023 Nov; 28(1):531. PubMed ID: 37980541
[TBL] [Abstract][Full Text] [Related]
5. Independent prognostic genes and mechanism investigation for colon cancer.
Li C; Shen Z; Zhou Y; Yu W
Biol Res; 2018 Apr; 51(1):10. PubMed ID: 29653552
[TBL] [Abstract][Full Text] [Related]
6. B7-H3 confers resistance to Vγ9Vδ2 T cell-mediated cytotoxicity in human colon cancer cells via the STAT3/ULBP2 axis.
Lu H; Ma Y; Wang M; Shen J; Wu H; Li J; Gao N; Gu Y; Zhang X; Zhang G; Shi T; Chen W
Cancer Immunol Immunother; 2021 May; 70(5):1213-1226. PubMed ID: 33119798
[TBL] [Abstract][Full Text] [Related]
7. DNM1: A Prognostic Biomarker Associated with Immune Infiltration in Colon Cancer-A Study Based on TCGA Database.
Hu M; Gu J; Su W; Zhang Z; Zhu B; Wang Q; Xing C
Biomed Res Int; 2021; 2021():4896106. PubMed ID: 34888380
[TBL] [Abstract][Full Text] [Related]
8. Identification and validation of an immune-associated RNA-binding proteins signature to predict clinical outcomes and therapeutic responses in colon cancer patients.
Sun D; Yang KS; Chen JL; Wang ZB
World J Surg Oncol; 2021 Oct; 19(1):314. PubMed ID: 34702278
[TBL] [Abstract][Full Text] [Related]
9. A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma.
Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC
Int J Med Sci; 2020; 17(13):1879-1896. PubMed ID: 32788867
[No Abstract] [Full Text] [Related]
10. An immune-related prognostic gene ULBP2 is correlated with immunosuppressive tumor microenvironment and immunotherapy in breast cancer.
Feng R; Xu J; Huang J; Liu J; Wang X; Wang J; Zhang C; Li H; Wei Y; Ren G
Heliyon; 2024 Jan; 10(1):e23687. PubMed ID: 38205308
[TBL] [Abstract][Full Text] [Related]
11. MiR-873, as a suppressor in cervical cancer, inhibits cells proliferation, invasion and migration via negatively regulating ULBP2.
Liang HX; Li YH
Genes Genomics; 2020 Apr; 42(4):371-382. PubMed ID: 31902110
[TBL] [Abstract][Full Text] [Related]
12. An Immune-Related Long Noncoding RNA Pair as a New Biomarker to Predict the Prognosis of Patients in Breast Cancer.
Jiang H; Sun J; Liu F; Wu X; Wen Z
Front Genet; 2022; 13():895200. PubMed ID: 35812755
[No Abstract] [Full Text] [Related]
13. Comprehensive Analysis of lncRNA-miRNA- mRNA Network Ascertains Prognostic Factors in Patients with Colon Cancer.
Gao Z; Fu P; Yu Z; Zhen F; Gu Y
Technol Cancer Res Treat; 2019; 18():1533033819853237. PubMed ID: 31159706
[TBL] [Abstract][Full Text] [Related]
14. Identification of immune infiltration-related LncRNA FAM83C-AS1 for predicting prognosis and immunotherapy response in colon cancer.
Li G; Feng H; Chen Q; Xue C; Li M; Liu X; Ma S
Transpl Immunol; 2021 Dec; 69():101481. PubMed ID: 34624486
[TBL] [Abstract][Full Text] [Related]
15. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
16. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of cell division cycle-associated protein-3 in prostate cancer.
Gu P; Zhang M; Chen X; Du J; Chen L; He X; Li M
Medicine (Baltimore); 2023 Sep; 102(36):e34655. PubMed ID: 37682152
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive
Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
Front Immunol; 2022; 13():931906. PubMed ID: 35958598
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel defined inflammation-related long noncoding RNA signature contributes to predicting prognosis and distinction between the cold and hot tumors in bladder cancer.
Xiong X; Chen C; Li X; Yang J; Zhang W; Wang X; Zhang H; Peng M; Li L; Luo P
Front Oncol; 2023; 13():972558. PubMed ID: 37064115
[TBL] [Abstract][Full Text] [Related]
20. Multi-omics analysis of tumor mutation burden combined with immune infiltrates in melanoma.
Jiang F; Wu C; Wang M; Wei K; Zhou G; Wang J
Clin Chim Acta; 2020 Dec; 511():306-318. PubMed ID: 33164879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
